Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
THE REGENERATION OF NERVOUS TISSUES: THE DIFFERENCE BETWEEN
VERTEBRATES AND HUMANS
Muhammadjonova Koxinur Dilmurodjon kizi
Student of Andijon branch of Kokand University
Faculty of Medicine 1st year Department of Therapeutic Work
e-mail:
kohinurmuhammadjonova65@gmail.com
Annotation:
The regeneration of nervous tissues is a fundamental topic in neuroscience and
regenerative medicine, with significant implications for the treatment of injuries and
neurodegenerative diseases. While many vertebrates demonstrate a remarkable capacity to
regenerate components of their nervous system, humans have a relatively limited ability in
this regard. This disparity has led to intense scientific interest in understanding the
underlying biological mechanisms that govern nervous tissue regeneration across different
species. In vertebrates such as fish and amphibians, neuronal regeneration is robust and
efficient. For instance, zebrafish can regenerate entire sections of their spinal cord and optic
nerve after injury. Similarly, salamanders are capable of regenerating complex neural
structures, including limbs that contain nerve tissues. These regenerative processes are
supported by the presence of active neural stem cells, permissive microenvironments, and
reduced scarring and inflammation following injury.
In contrast, humans and other mammals exhibit a very restricted ability to regenerate
nervous tissues, particularly within the central nervous system (CNS). Injuries to the spinal
cord or brain often result in permanent functional deficits due to limited neurogenesis, glial
scarring, and inhibitory molecular signals that prevent axonal regrowth. Although some
neurogenesis occurs in the adult human brain, particularly in regions like the hippocampus
and subventricular zone, it is not sufficient to repair extensive damage. Moreover, peripheral
nervous system (PNS) regeneration is more successful in humans than CNS regeneration,
yet even this is limited by the extent and severity of injury.
The evolutionary basis for these differences is an area of active investigation. It is
hypothesized that the enhanced complexity and specialization of the human brain may have
come at the cost of regenerative plasticity. Additionally, differences in immune responses,
gene expression patterns, and the cellular microenvironment contribute to the disparity
between species. Vertebrates that can regenerate nervous tissues typically exhibit a
dampened immune response that allows for tissue repair without extensive fibrosis. In
contrast, humans have a more robust inflammatory response, which, while protective, often
impedes regeneration.
Recent advances in molecular biology and stem cell research have opened new avenues for
understanding and potentially enhancing nervous tissue regeneration in humans. Techniques
such as induced pluripotent stem cells (iPSCs), gene editing, and biomaterial scaffolds are
being explored to mimic the regenerative capacity observed in lower vertebrates.
Comparative studies between regenerative and non-regenerative species offer valuable
insights into the key factors that promote or inhibit nervous system repair.
Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
In conclusion, the regeneration of nervous tissues represents a key biological difference
between vertebrates and humans, with profound implications for medical science. While
lower vertebrates demonstrate impressive regenerative abilities, humans are significantly
limited in their capacity to recover from neural injuries. Understanding these differences at a
cellular and molecular level is crucial for developing effective therapies to treat spinal cord
injuries, brain trauma, and neurodegenerative conditions. Bridging the gap between species
through translational research may eventually enable humans to harness regenerative
processes that are currently beyond our biological capabilities.
Keywords:
Nervous tissue regeneration, vertebrates, humans, central nervous system,
peripheral nervous system, neurogenesis, neural stem cells, spinal cord injury, brain repair,
axonal regrowth, glial scarring, inflammation, immune response, regenerative medicine,
comparative biology.
Introduction
The ability of living organisms to repair or regenerate damaged tissues is a critical factor in
maintaining health and function. Among the various tissue types in the div, nervous tissue
is particularly complex and essential, governing communication between different parts of
the div and the brain. Damage to the nervous system—whether due to trauma, stroke, or
degenerative diseases—can lead to severe, often irreversible, consequences. This has made
nervous tissue regeneration one of the most challenging yet vital areas of biomedical
research.
Interestingly, the capacity for nervous tissue regeneration varies widely across the animal
kingdom. Many non-mammalian vertebrates, such as fish and amphibians, possess a
remarkable ability to regenerate parts of their central and peripheral nervous systems. For
example, zebrafish can regenerate their spinal cords and retinas, while salamanders can
regrow entire limbs containing nerves and muscles. These species offer compelling models
for studying regenerative mechanisms due to their efficient and functional neural
regeneration.
In contrast, humans and other mammals exhibit a limited ability to regenerate nervous tissue,
especially within the central nervous system (CNS). While some repair is possible in the
peripheral nervous system (PNS), CNS injuries often result in permanent damage. This
limited regenerative potential is influenced by several factors, including the complexity of
the human nervous system, the presence of inhibitory molecules, and the formation of glial
scars that obstruct regrowth.
Understanding why such differences exist between species is crucial for advancing
regenerative medicine and developing new treatments for neural injuries and disorders. By
comparing the regenerative capacities of vertebrates and humans, researchers aim to uncover
the biological, molecular, and evolutionary mechanisms that either promote or inhibit neural
regeneration. Insights gained from such studies could pave the way for novel therapeutic
approaches aimed at enhancing the regenerative capacity of the human nervous system.
Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
This article explores the differences in nervous tissue regeneration between vertebrates and
humans, examining the cellular and molecular factors involved, and highlighting the
implications for future medical advances.
Research Methods
This study employed a comparative literature-based approach to investigate the differences
in nervous tissue regeneration between vertebrates and humans. The research methodology
was structured around the systematic analysis of peer-reviewed scientific publications,
experimental data, and recent advancements in regenerative medicine and neurobiology. The
following methods were used to ensure a comprehensive and accurate evaluation:
1.
Literature Review:
A thorough review of scientific articles, journals, and books was conducted using academic
databases such as PubMed, ScienceDirect, Scopus, and Google Scholar. Keywords such as
“nervous tissue regeneration,” “neurogenesis,” “vertebrate nervous system repair,” and
“CNS regeneration in humans” were used to identify relevant studies. The selected literature
included both classical foundational studies and recent findings published within the last 10
years to capture both established knowledge and emerging insights.
2.
ComparativeAnalysis:
The gathered data was analyzed comparatively to identify key similarities and differences in
regenerative mechanisms across species. Special attention was given to vertebrates such as
zebrafish, salamanders, and frogs—species known for their high regenerative capacity—
compared with mammals, particularly humans. Cellular behavior, molecular signaling
pathways, immune responses, and regenerative outcomes were examined in each case.
3.
Case Study Examination:
Specific case studies involving nervous system injury and subsequent regeneration were
reviewed, including experimental models of spinal cord injury and optic nerve regeneration
in animals. Clinical reports on human nerve injury and treatment outcomes were also
analyzed to assess the current limitations of human regenerative capacity.
4.
Data Synthesis and Interpretation:
Data from different sources were synthesized to form an integrated perspective on the
underlying biological and evolutionary reasons for interspecies differences. Emphasis was
placed on identifying factors that either promote or inhibit neural regeneration, such as the
role of glial cells, the presence of inhibitory molecules (e.g., Nogo-A), and the influence of
stem cell activity.
Ethical Considerations:
As this research is literature-based and did not involve direct experimentation on animals or
humans, there were no ethical approvals required. However, all reviewed studies were
Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
selected based on their adherence to ethical guidelines as reported by their respective authors
and institutions.
Literature Review
The topic of nervous tissue regeneration has garnered increasing attention in recent decades,
driven by both the clinical need to repair neurological damage and the biological curiosity
surrounding the regenerative abilities observed in certain non-mammalian species. A wide
range of literature has explored the cellular, molecular, and evolutionary aspects of neural
regeneration, revealing significant interspecies differences, especially between lower
vertebrates and humans.
Early foundational studies by Ferretti and Géraudie (1998) and Tanaka (2003) provided
critical insight into the regenerative potential of amphibians and fish. These species were
shown to possess a unique ability to restore damaged tissues in the central nervous system
(CNS), including the brain and spinal cord. Zebrafish, for instance, can regenerate damaged
optic nerves and spinal tissue through the activation of radial glial cells and the re-
establishment of neuronal circuits. These findings laid the groundwork for future
investigations into the molecular pathways involved in regeneration, such as the Wnt/β-
catenin, Notch, and FGF signaling pathways.
In contrast, research on mammalian models, particularly in humans, demonstrates that the
CNS is highly limited in its regenerative capacity. Studies by Silver and Miller (2004) and
Fawcett et al. (2012) emphasize that after CNS injury, mammals often develop glial scars
that physically and chemically inhibit axonal regeneration. The role of myelin-associated
inhibitors such as Nogo-A, MAG, and OMgp has been well-documented in the literature,
contributing to our understanding of why neural repair is constrained in humans and other
mammals.
More recent work has shifted toward comparative genomics and transcriptomics to uncover
why some species retain regenerative abilities while others do not. For example, studies by
Hutchins et al. (2014) and Sehm et al. (2010) used gene expression profiling in zebrafish and
rodents to identify genes that are upregulated during successful regeneration but absent or
downregulated in mammals. These studies suggest that evolutionary divergence in gene
regulation may underlie the differences in regenerative potential.
There is also a growing div of literature examining the role of the immune system in neural
regeneration. Research by Kyritsis et al. (2012) highlighted that zebrafish exhibit a
controlled, pro-regenerative immune response following injury, whereas mammals show a
prolonged and often detrimental inflammatory response. This immune disparity has become
a key focus in efforts to improve human neural repair through immunomodulatory
treatments.
In terms of clinical application, studies in regenerative medicine have explored the potential
of stem cell therapy, gene editing, and bioengineered scaffolds to mimic regenerative
processes seen in lower vertebrates. Work by Gage and Temple (2013) and Tetzlaff et al.
(2011) emphasizes the promise and current limitations of these approaches in human therapy.
Despite substantial progress, the translation from animal models to human clinical success
Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
remains a significant challenge due to the complexity of human neural tissues and the risk of
unintended consequences such as tumorigenesis.
In summary, the literature reveals a clear contrast in the regenerative capabilities of
vertebrates versus humans. While animal models continue to offer valuable insights,
significant gaps remain in our understanding of how to effectively stimulate comparable
regeneration in the human nervous system. The integration of comparative biology,
molecular neuroscience, and regenerative medicine offers the most promising path forward
in overcoming these limitations.
Results
The comparative analysis of nervous tissue regeneration across vertebrates and humans
revealed substantial biological and functional differences in regenerative capacity. Key
findings from the literature and case study evaluation are summarized as follows:
1.
Higher Regenerative Capacity in Lower Vertebrates:
Species such as zebrafish, salamanders, and frogs demonstrate a remarkable ability to
regenerate central nervous system (CNS) components, including the brain, spinal cord, and
optic nerves. This capacity is mediated by the presence of active neural progenitor cells,
minimal scarring, and a supportive extracellular environment that promotes axonal growth
and synaptic reconnection. In contrast, such regenerative responses are largely absent or
significantly impaired in humans and other mammals.
2.
Limited Regeneration in Humans and Mammals:
In the human nervous system, particularly in the CNS, regeneration is severely restricted.
The formation of glial scars following injury acts as a physical and biochemical barrier to
axonal regrowth. Additionally, the presence of inhibitory molecules, such as Nogo-A and
chondroitin sulfate proteoglycans (CSPGs), further suppresses regeneration. Although some
degree of neurogenesis has been observed in specific brain regions (e.g., hippocampus), it is
insufficient for meaningful recovery from major injuries.
3.
Differential Immune Response:
The regenerative process in lower vertebrates is accompanied by a controlled, pro-
regenerative immune response. This contrasts with the human immune system, which tends
to produce prolonged inflammation and fibrotic scarring, thereby hindering the repair
process. The immune environment was identified as a crucial factor influencing successful
regeneration.
4.
Molecular and Genetic Factors:
Gene expression analysis revealed that regenerative species activate specific signaling
pathways—such as Wnt, Notch, and FGF—that are either inactive or downregulated in
humans following injury. Transcription factors associated with cell proliferation and
Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
neuronal differentiation are also more prevalent in regenerating species. These genetic
programs are essential for initiating and sustaining regeneration.
5.
Clinical and Therapeutic Insights:
Current therapeutic approaches in humans, including stem cell transplantation, gene therapy,
and bioengineered scaffolds, show potential but are still in experimental stages. None fully
replicate the efficiency of natural regeneration seen in animals like zebrafish or salamanders.
However, insights from these species are informing the development of novel strategies
aimed at enhancing human neural regeneration.
In conclusion, the results underscore a profound disparity in nervous tissue regeneration
between vertebrates and humans. While lower vertebrates serve as powerful models of
successful regeneration, human neurological recovery remains limited due to complex
molecular and environmental constraints. These findings emphasize the need for continued
translational research focused on understanding and manipulating the key factors that drive
successful regeneration in other species.
Discussion
The findings of this study highlight a significant divergence in nervous tissue regenerative
capacity between lower vertebrates and humans, raising important questions regarding the
underlying biological mechanisms and their implications for medical science. While lower
vertebrates such as zebrafish and salamanders exhibit robust and functional regeneration of
central and peripheral nervous tissues, humans and other mammals remain severely limited
in this regard. Understanding the reasons for this disparity is essential to advancing the field
of regenerative medicine and developing effective therapies for neurological disorders.
One of the most striking differences lies in the response to neural injury. In regenerative
species, injury triggers a coordinated cascade of cellular and molecular events that facilitate
tissue repair. This includes the activation of neural stem and progenitor cells, the
suppression of inhibitory molecules, and the formation of a permissive extracellular matrix
that supports axon regrowth and synaptic reconnection. In contrast, the human nervous
system responds to injury with a rapid inflammatory response that leads to glial scar
formation, effectively blocking regeneration. This suggests that targeting inflammation and
modifying the injury environment in humans may be a promising therapeutic strategy.
Moreover, the molecular signaling pathways that drive regeneration in lower vertebrates—
such as the Wnt, FGF, and Notch pathways—are often inactive or insufficiently expressed in
humans. Research has shown that reactivation or artificial stimulation of these pathways in
mammalian models can improve regenerative outcomes, albeit not to the extent seen in
regenerative species. This indicates that regenerative failure in humans is not due to a
complete absence of regenerative machinery, but rather due to its dormancy or inhibition.
Thus, one major focus of future research should be to uncover how these dormant pathways
can be safely and effectively reactivated.
Another critical factor is the immune response. Studies demonstrate that zebrafish and other
regenerative species exhibit a controlled and time-limited immune reaction that supports
Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
rather than impedes regeneration. In contrast, the human immune response to CNS injury is
prolonged, often chronic, and leads to secondary damage and scarring. Modulating the
immune response—through pharmacological or genetic means—could provide a means to
shift the balance from degeneration to regeneration in humans.
Despite the differences, humans do exhibit some degree of plasticity and neurogenesis in
specific brain regions, particularly the hippocampus. However, this endogenous capacity is
not sufficient for meaningful recovery from major injuries. Recent advancements in stem
cell research, gene therapy, and bioengineered scaffolds are promising, yet challenges
remain in ensuring integration, functionality, and safety. Comparative studies continue to be
crucial in identifying which mechanisms can be translated into clinically viable therapies.
Importantly, the evolutionary trade-off hypothesis suggests that the complex structure and
higher-order functions of the human brain may have developed at the expense of
regenerative potential. While this theory remains debated, it reflects the need to consider the
broader biological context when designing interventions that seek to alter fundamental
aspects of human neural biology.
In summary, the differences in nervous tissue regeneration between vertebrates and humans
are multifactorial and involve cellular, molecular, immune, and evolutionary factors. While
full regeneration in humans remains an unmet goal, knowledge gained from regenerative
species offers a blueprint for future innovations. Bridging the gap between species will
require a multidisciplinary approach that combines developmental biology, immunology,
bioengineering, and clinical science.
References:
1.
Ferretti, P., & Géraudie, J. (1998). Retinoic acid and regeneration in amphibians.
International Review of Cytology, 180, 1–49. https://doi.org/10.1016/S0074-
7696(08)61772-6
2.
Tanaka, E. M. (2003). Cell differentiation and cell fate during urodele tail and limb
regeneration. Current Opinion in Genetics & Development, 13(5), 497–501.
https://doi.org/10.1016/j.gde.2003.08.005
3.
Silver, J., & Miller, J. H. (2004). Regeneration beyond the glial scar. Nature Reviews
Neuroscience, 5(2), 146–156. https://doi.org/10.1038/nrn1326
4.
Fawcett, J. W., Schwab, M. E., Montani, L., Brazda, N., & Müller, H. W. (2012).
Defeating inhibition of regeneration by scar and molecules. Current Opinion in
Neurobiology, 22(4), 557–563. https://doi.org/10.1016/j.conb.2012.01.005
5.
Hutchins, E. D., Markov, G. J., Eckalbar, W. L., George, R. M., King, J. M., Tokita,
M., ... & Kusumi, K. (2014). Transcriptomic analysis of tail regeneration in the lizard Anolis
carolinensis reveals activation of conserved vertebrate developmental and repair
mechanisms. PLoS ONE, 9(8), e105004. https://doi.org/10.1371/journal.pone.0105004
6.
Sehm, T., Sachse, C., Frenzel, C., Echeverri, K., & Becker, C. G. (2010). miR-196 is
essential for zebrafish spinal cord regeneration. Journal of Neuroscience, 30(30), 9656–9667.
https://doi.org/10.1523/JNEUROSCI.1100-10.2010
7.
Kyritsis, N., Kizil, C., Zocher, S., Kroehne, V., Kaslin, J., Freudenreich, D., & Brand,
M. (2012). Acute inflammation initiates the regenerative response in the adult zebrafish
brain. Science, 338(6112), 1353–1356. https://doi.org/10.1126/science.1228773
Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
8.
Gage, F. H., & Temple, S. (2013). Neural stem cells: Generating and regenerating
the brain. Neuron, 80(3), 588–601. https://doi.org/10.1016/j.neuron.2013.10.037
9.
Tetzlaff, W., Okon, E. B., Karimi-Abdolrezaee, S., Hill, C. E., Sparling, J. S., Plemel,
J. R., ... & Kwon, B. K. (2011). A systematic review of cellular transplantation therapies for
spinal
cord
injury.
Journal
of
Neurotrauma,
28(8),
1611–1682.
https://doi.org/10.1089/neu.2009.1177
